Pinoresinol 4-O-beta-D-glucopyranoside (Standard) is the analytical standard of Pinoresinol 4-O-beta-D-glucopyranoside (HY-N2168). This product is intended for research and analytical applications. Pinoresinol 4-O-beta-D-glucopyranoside is an orally active alpha-glucosidase inhibitor, with an IC50 of 48.13 µg/mL. Pinoresinol 4-O-beta-D-glucopyranoside binds to estrogen receptors. Pinoresinol 4-O-beta-D-glucopyranoside inhibits phosphodiesterase. Pinoresinol 4-O-beta-D-glucopyranoside exhibits various activities such as antioxidant, anti-inflammatory, anti-hyperglycemic, hepatoprotective and anti-epileptic effects[1][2][3][4][5][6][7][8].
